Moderna
MRNA
#894
Rank
HK$216.82 B
Marketcap
HK$546.44
Share price
3.61%
Change (1 day)
152.31%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of March 2026 : HK$10.17 Billion

According to Moderna 's latest financial reports the company's total debt is HK$10.17 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$10.15 B75.08%
2024-12-31HK$5.79 B-40.26%
2023-12-31HK$9.70 B3.54%
2022-12-31HK$9.37 B31.27%
2021-12-31HK$7.14 B288.76%
2020-12-31HK$1.83 B78.23%
2019-12-31HK$1.03 B293.09%
2018-12-31HK$0.26 B113.97%
2017-12-31HK$0.12 B26.44%
2016-12-31HK$96.93 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.09 B 4,136.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$368.45 B 3,520.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$385.07 B 3,684.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$10.98 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.14 B-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$9.98 B-1.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$7.75 B-23.77%๐Ÿ‡บ๐Ÿ‡ธ USA